Follow-The-Filings

CTXR Citius Pharmaceuticals

Citius Pharmaceuticals earnings company data as of 7:18 PM ET 8/21

  • 1 of 1 EPS beats

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q3 14 Aug EPS -0.36 -0.34 Beat
Rev $1.5M

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 3.01
8-K 2.02,9.01
10-Q QUARTERLY REPORT
8-K 8.01,9.01
8-K 8.01,9.01
10-Q QUARTERLY REPORT
8-K 2.02,9.01
8-K 1.01,9.01
8-K 3.02,8.01,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,8.01,9.01
8-K 5.07
8-K 8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
10-Q QUARTERLY REPORT
8-K 2.02,3.01,9.01
10-K/A AMENDMENT NO. 1 TO FORM 10-K
10-K ANNUAL REPORT
8-K 2.02,9.01
8-K 7.01,8.01,9.01
8-K 7.01,9.01
424B5 PROSPECTUS SUPPLEMENT
8-K 1.01,8.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed Form Detail Links
4 Period Aug 8, 2025
4 Period Aug 8, 2025

Consensus estimates · SEC filings remain the official record · not investment advice